Background & Aims Helicobacter pylori infection is increasingly difficult to treat. The purpose
of these consensus statements is to provide a review of the literature and specific, updated …

Management of Helicobacter pylori infection is evolving and in this 4th edition of the
Maastricht consensus report aspects related to the clinical role of H pylori were looked at …

Objective The best approach for Helicobacter pylori management remains unclear. An audit
process is essential to ensure clinical practice is aligned with best standards of care. Design …

Helicobacter pylori infection contributes to the development of diverse gastric and
extragastric diseases. The infection is necessary but not sufficient for the development of …

Data are available such that choice of Helicobacter pylori therapy for an individual patient
can be reliably predicted. Here, treatment success is defined as a cure rate of 90% or …

Background Helicobacter pylori is associated with benign and malignant diseases of the
upper gastrointestinal tract, and increasing antibiotic resistance has made alternative …

The K orean C ollege of H elicobacter and U pper G astrointestinal R esearch first
developed guidelines for the diagnosis and treatment of H elicobacter pylori (H. pylori) …

Objective: As the clinical implications of Helicobacter pylori infection in children and
adolescents continue to evolve, ESPGHAN and NASPGHAN jointly renewed clinical …

We provide a primer to assist in the difficult transition of Helicobacter pylori therapy
guidelines to those that adhere to the principles of antimicrobial stewardship. This transition …

AIM: To summarize the evidence from randomized controlled trials (RCTs) regarding the
effect of probiotics by using a meta-analytic approach. METHODS: In July 2013, we …